VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO 2015 | Current clinical perspectives on targeted therapy and immunotherapy for melanoma

Caroline Robert • 30 May 2015
ASCO 2015
Skin Cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Caroline Robert, MD, PhD, from Institut Gustave Roussy, Villejuif, France, considers the impact of available and emerging targeted therapies and immunotherapies on the current treatment landscape in melanoma.

More from Caroline Robert

1:41
How can patients undergoing immunotherapy be supported?
Caroline Robert • 8 Sep 2017
2:21
When should treatment be stopped?
Caroline Robert • 8 Sep 2017
1:26
Metastatic melanoma: the CheckMate 067 and 069 trials
Caroline Robert • 8 Sep 2017
5:40
Immunotherapy and targeted therapies for melanoma
Caroline Robert • 30 May 2015

Related Videos

1:40
Gray color in dermatoscopy
Iris Zalaudek • 29 Oct 2020
2:08
Managing BCC lesions in NBCCS
Iris Zalaudek • 29 Oct 2020
2:12
Melanoma Patient Network Europe
Bettina Ryll • 14 Oct 2020
3:25
Access to novel therapies in melanoma
Bettina Ryll • 14 Oct 2020
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals